Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
The absence of fucose on asparagine-297 of the human immunoglobulin G (IgG) heavy chain has been shown to enhance antibody-dependent cellular cytotoxicity (ADCC) activity by 10- to 100-fold compared to fucosylated antibody. Our lab is studying the use of adeno-associated virus (AAV) as a vector for...
Main Authors: | James M. Termini, José M. Martinez-Navio, Guangping Gao, Sebastian P. Fuchs, Ronald C. Desrosiers |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S232905012030228X |
Similar Items
-
Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
by: José M. Martinez-Navio, et al.
Published: (2020-03-01) -
Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
by: Kate J. Dixon, et al.
Published: (2021-01-01) -
Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity
by: Melissa eBartel, et al.
Published: (2011-10-01) -
Humoral immune response to AAV
by: Roberto eCalcedo, et al.
Published: (2013-10-01) -
Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART® Molecules
by: Marina Tuyishime, et al.
Published: (2021-08-01)